Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells

Journal of Medical Virology

Volumn 82, Issue 11, 2010, Pages 1950-1957

  Nair, Sandhya ^a,b   Leung, Kin Chuen ^c,d   Rawlinson, William D ^a,b   Naing, Zin ^a   Craig, Maria E ^a,b,d,e  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Institute of Endocrinology and Diabetes   (Australia)

Author keywords

C C chemokines; Coxsackievirus B; CXCL10; Interferon; TNF ; Type 1 diabetes

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ENTEROVIRUS; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA; METABOLISM; PANCREAS ISLET BETA CELL; PATHOGENICITY; RAT; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CELL LINE, TUMOR; CHEMOKINE CXCL10; CHEMOKINES; CHEMOKINES, CC; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; HUMANS; INFLAMMATION; INSULIN-SECRETING CELLS; INSULINOMA; INTERFERONS; RATS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952116542     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21900     Document Type: Article

References (37)

1. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. 2005. Natural history of type 1 diabetes. Diabetes 54: S25-S31.
2. Blomqvist S, Paananen A, Savolainen-Kopra C, Hovi T, Roivainen M. 2008. Eight years of experience with molecular identification of human enteroviruses. J Clin Microbiol 46: 2410-2413.
3. Cabrera-Rode E, Sarmiento L, Tiberti C, Molina G, Barrios J, Hernandez D, Diaz-Horta O, Di Mario U. 2003. Type 1 diabetes islet associated antibodies in subjects infected by echovirus 16. Diabetologia 46: 1348-1353.
4. Christen U, von Herrath MG. 2004. IP-10 and type 1 diabetes: A question of time and location. Autoimmunity 37: 273-282.
5. Christen U, Wolfe T, Mohrle U, Hughes AC, Rodrigo E, Green EA, Flavell RA, von Herrath MG. 2001. A dual role for TNF-alpha in type 1 diabetes: Islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J Immunol 166: 7023-7032.
6. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MBA. 2003. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171: 6838-6845.
7. Craig ME, Howard NJ, Silink M, Rawlinson WD. 2003a. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 187: 1562-1570.
8. Craig ME, Robertson P, Howard NJ, Silink M, Rawlinson WD. 2003b. Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J Clin Microbiol 41: 841-844.
9. Dinarello CA. 2007. Historical insights into cytokines. Eur J Immunol 37: S34-S45.
10. Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T, Donath MY, Storling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T. 2008. Cytokines and beta-cell biology: From concept to clinical translation. Endocr Rev 29: 334-350.
11. Dotta F, Censini S, van Halteren AGS, Marselli L, Masini M, Dionisi S, Mosca F, Boggi U, Muda AO, Prato SD, Elliott JF, Covacci A, Rappuoli R, Roep BO, Marchetti P. 2007. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 104: 5115-5120.
12. Elshebani A, Olsson A, Westman J, Tuvemo T, Korsgren O, Frisk G. 2007. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes. Virus Res 124: 193-203.
13. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L. 2002. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8: 1414-1420.
14. Green EA, Eynon EE, Flavell RA. 1998. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9: 733-743.
15. Halim S, Ramsingh AI. 2000. A point mutation in VP1 of coxsackievirus B4 alters antigenicity. Virology 269: 86-94.
16. Jaidane H, Hober D. 2008. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 34: 537-548.
17. Martino TA, Petric M, Brown M, Aitken K, Gauntt CJ, Richardson CD, Chow LH, Liu PP. 1998. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor. Virology 244: 302-314.
18. Olsson A, Johansson U, Korsgren O, Frisk G. 2005. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans. Biochem Biophys Res Commun 330: 571-576.
19. Otonkoski T, Roivainen M, Vaarala O, Dinesen B, Leipala JA, Hovi T, Knip M. 2000. Neonatal type I diabetes associated with maternal echovirus 6 infection: A case report. Diabetologia 43: 1235-1238.
20. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. 2009. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52: 1143-1151.
21. Richer MJ, Horwitz MS. 2008. Viral infections in the pathogenesis of autoimmune diseases: Focus on type 1 diabetes. Front Biosci 13: 4241-4257.
22. Roivainen M. 2006. Enteroviruses: New findings on the role of enteroviruses in type 1 diabetes. Int J Biochem Cell Biol 38: 721-725.
23. Roivainen M, Knip M, Hyoty H, Kulmala P, Hiltunen M, Vahasalo P, Hovi T, Akerblom HK. 1998. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 56: 74-78.
24. Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T. 2000. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 85: 432-440.
25. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. 2002. Functional impairment and killing of human beta cells by enteroviruses: The capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45: 693-702.
26. Salminen K, Sadeharju K, Lonnrot M, Vahasalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyoty H. 2003. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 69: 91-98.
27. Sarmiento L, Cabrera-Rode E, Lekuleni L, Cuba I, Molina G, Fonseca M, Heng-Hung L, Borroto AD, Gonzalez P, Mas-Lago P, Diaz-Horta O. 2007. Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes. Autoimmunity 40: 540-545.
28. Schall TJ, Bacon KB. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 6: 865-873.
29. Serreze DV, Wasserfall C, Ottendorfer EW, Stalvey M, Pierce MA, Gauntt C, O'Donnell B, Flanagan JB, Campbell-Thompson M, Ellis TM, Atkinson MA. 2005. Diabetes acceleration or prevention by a coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon. J Virol 79: 1045-1052.
30. Shimada A, Morimoto J, Kodama K, Suzuki R, Oikawa Y, Funae O, Kasuga A, Saruta T, Narumi S. 2001. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24: 510-515.
31. Stechova K, Bohmova K, Vrabelova Z, Sepa A, Stadlerova G, Zacharovova K, Faresjo M. 2007. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 23: 462-471.
32. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW. 2009. Beta cell apoptosis in diabetes. Apoptosis 14: 1389-1404.
33. van den Berk LCJ, Jansen BJH, Siebers-Vermeulen KG, Roelofs H, Figdor CG, Adema GJ, Torensma R. 2010. Mesenchymal stem cells respond to TNF but do not produce TNF. J Leukoc Biol 87: 283-289.
34. Vreugdenhil GR, Schloot NC, Hoorens A, Rongen C, Pipeleers DG, Melchers WJ, Roep BO, Galama JM. 2000. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: Putative pathogenic pathways. Clin Infect Dis 31: 1025-1031.
35. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. 2009. Analysis of islet inflammation in human type 1 diabetes [see comment]. Clin Exp Immunol 155: 173-181.
36. Ylipaasto P, Kutlu B, Rasilainen S, Rasschaert J, Salmela K, Teerijoki H, Korsgren O, Lahesmaa R, Hovi T, Eizirik DL, Otonkoski T, Roivainen M. 2005. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 48: 1510-1522.
37. Zanone MM, Favaro E, Conaldi PG, Greening J, Bottelli A, Perin PC, Klein NJ, Peakman M, Camussi G. 2003. Persistent infection of human microvascular endothelial cells by coxsackie B viruses induces increased expression of adhesion molecules. J Immunol 171: 438-446.